These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39293689)

  • 1. Multiscale spatio-temporal dynamics of UBE3A gene in brain physiology and neurodevelopmental disorders.
    Biagioni M; Baronchelli F; Fossati M
    Neurobiol Dis; 2024 Oct; 201():106669. PubMed ID: 39293689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
    LaSalle JM; Reiter LT; Chamberlain SJ
    Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome.
    Copping NA; Christian SGB; Ritter DJ; Islam MS; Buscher N; Zolkowska D; Pride MC; Berg EL; LaSalle JM; Ellegood J; Lerch JP; Reiter LT; Silverman JL; Dindot SV
    Hum Mol Genet; 2017 Oct; 26(20):3995-4010. PubMed ID: 29016856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between UBE3A and SNORD116 expression and features of autism in chromosome 15 imprinting disorders.
    Baker EK; Butler MG; Hartin SN; Ling L; Bui M; Francis D; Rogers C; Field MJ; Slee J; Gamage D; Amor DJ; Godler DE
    Transl Psychiatry; 2020 Oct; 10(1):362. PubMed ID: 33116122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of CTCF loops, methylome, and transcriptome in differentiating LUHMES as a model for imprinting dynamics of the 15q11-q13 locus in human neurons.
    Gutierrez Fugón OJ; Sharifi O; Heath N; Soto DC; Gomez JA; Yasui DH; Mendiola AJP; O'Geen H; Beitnere U; Tomkova M; Haghani V; Dillon G; Segal DJ; LaSalle JM
    Hum Mol Genet; 2024 Sep; 33(19):1711-1725. PubMed ID: 39045627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of UBE3A in the autism and epilepsy-related Dup15q syndrome using patient-derived, CRISPR-corrected neurons.
    Elamin M; Dumarchey A; Stoddard C; Robinson TM; Cowie C; Gorka D; Chamberlain SJ; Levine ES
    Stem Cell Reports; 2023 Apr; 18(4):884-898. PubMed ID: 36898382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome.
    Krzeski JC; Judson MC; Philpot BD
    Curr Opin Neurobiol; 2024 Oct; 88():102899. PubMed ID: 39126903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant transcriptional changes in 15q duplication but not Angelman syndrome deletion stem cell-derived neurons.
    Urraca N; Hope K; Victor AK; Belgard TG; Memon R; Goorha S; Valdez C; Tran QT; Sanchez S; Ramirez J; Donaldson M; Bridges D; Reiter LT
    Mol Autism; 2018; 9():6. PubMed ID: 29423132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature.
    Aguilera C; Viñas-Jornet M; Baena N; Gabau E; Fernández C; Capdevila N; Cirkovic S; Sarajlija A; Miskovic M; Radivojevic D; Ruiz A; Guitart M
    BMC Med Genet; 2017 Nov; 18(1):137. PubMed ID: 29162042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation.
    Powell WT; Coulson RL; Gonzales ML; Crary FK; Wong SS; Adams S; Ach RA; Tsang P; Yamada NA; Yasui DH; Chédin F; LaSalle JM
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13938-43. PubMed ID: 23918391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep EEG signatures in mouse models of 15q11.2-13.1 duplication (Dup15q) syndrome.
    Saravanapandian V; Madani M; Nichols I; Vincent S; Dover M; Dikeman D; Philpot BD; Takumi T; Colwell CS; Jeste S; Paul KN; Golshani P
    J Neurodev Disord; 2024 Jul; 16(1):39. PubMed ID: 39014349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes.
    Mabb AM; Judson MC; Zylka MJ; Philpot BD
    Trends Neurosci; 2011 Jun; 34(6):293-303. PubMed ID: 21592595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and behavioral consequences of Ube3a gene overdosage in mice.
    Punt AM; Judson MC; Sidorov MS; Williams BN; Johnson NS; Belder S; den Hertog D; Davis CR; Feygin MS; Lang PF; Jolfaei MA; Curran PJ; van IJcken WF; Elgersma Y; Philpot BD
    JCI Insight; 2022 Sep; 7(18):. PubMed ID: 36134658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards an understanding of Angelman syndrome in mice studies.
    Yang X
    J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice.
    Schmid RS; Deng X; Panikker P; Msackyi M; Breton C; Wilson JM
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33411694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion.
    Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM
    Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes.
    Kalsner L; Chamberlain SJ
    Pediatr Clin North Am; 2015 Jun; 62(3):587-606. PubMed ID: 26022164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From pathogenesis to treatment of genetic intellectual disabilities: a lesson from Angelman syndrome research].
    Saitoh S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Jun; 33(3):127-30. PubMed ID: 25069246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angelman Syndrome: From Mouse Models to Therapy.
    Rotaru DC; Mientjes EJ; Elgersma Y
    Neuroscience; 2020 Oct; 445():172-189. PubMed ID: 32088294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.